-+ 0.00%
-+ 0.00%
-+ 0.00%
Ticketplus (NYSEAM:TP) Stock Stalls As Q3 Earnings Spotlight Profit Quality
Share
Listen to the news

Ticketplus just released its first post‑IPO scorecard for Q3 2026, and the headline is clear. Revenue reached US$14.4m while gross merchandise value inched toward US$177.5m, yet the share price did not move today. That flat tape comes after a softer 7‑day run for the stock, which makes the muted reaction feel more like indecision than conviction.

The central focus is profitability. Net income of US$1.6m sits alongside Adjusted EBITDA of US$6.1m, and investors now have to decide whether this margin profile justifies paying less attention to the latest growth in ticket volume.

Impressed by Ticketplus turning a profit but unsure whether this margin mix justifies the current hesitation in the share price? Compare it with a curated list of companies that pair disciplined profitability with sturdier financial profiles in our list of solid balance sheet and fundamentals stocks (22 results)

Q3 2026 Ticketplus Earnings Summary

  • Revenue (Q3 2026 vs. Q3 2025): US$14.35m vs. US$7.94m (up 80.8%)
  • Net Income (Q3 2026 vs. Q3 2025): US$1.60m vs. US$0.38m (up 325.0%)
  • Basic EPS (Q3 2026 vs. Q3 2025): US$0.14 vs. US$0.04 (up 271.7%)
  • Net Margin (TTM to Q3 2026 vs. prior year): 13.4% vs. 8.6% (improved profitability)

White-label ticketing now drives most of Ticketplus’s platform sales. Ask Charlie what makes Ticketplus’s white-label growth stand out.

NYSEAM:TP Trailing 12-Month Earnings & Revenue History as at Oct 2026
NYSEAM:TP Trailing 12-Month Earnings & Revenue History as at Oct 2026

Ticketplus earnings momentum backs upbeat narrative

For anyone leaning optimistic on Ticketplus, the latest quarter lines up cleanly with that view. Revenue and GMV both moved sharply higher, while gross margin widened to 49% and Adjusted EBITDA margin reached 42.6%. That is a rare combination of scale and efficiency for a relatively young public platform. White label activity now accounts for a majority of GMV, which fits the idea of Ticketplus as infrastructure rather than just another ticket seller and suggests the model is gaining traction across more partners and countries.

Profit mix and reinvestment temper simple bull story

The flip side is that some bear talking points still have teeth. The stock has drifted over the past week even with positive Q3, which indicates that investors are weighing execution risk. Capitalized software development ran as high as 37.8% of year to date revenue, so a large portion of cash is cycling back into the product. That can support future competitiveness, yet it also means free cash generation is less clear cut than headline profitability might imply for Ticketplus right now.

Are analysts treating Ticketplus’ mix of infrastructure style white label GMV and high Adjusted EBITDA margin as sustainable, or trimming expectations? See the consensus price target analysis for Ticketplus.

Hunt For Quietly Mispriced Cash Flows

Ticketplus just reported its first clear view of post IPO profitability while the share price showed little movement. The real opportunity could be finding mispriced balance sheet strength and durable cash engines before consensus narrows the valuation gap.

  • Company 1 - 24% below our estimate - sell test and diagnostic systems utilities rely on as they modernize aging grids.
  • Company 2 - 26% below our estimate - anchor specialized chips and software where large data and networking workloads run securely.
  • Company 3 - 50% below our estimate - extend an aviation aftermarket platform that integrates acquired repair shops into higher margin programs.

Three companies from the same screener. Open all 30 potentially undervalued companies →

Disclaimer:This article represents the opinion of the author only. It does not represent the opinion of Webull, nor should it be viewed as an indication that Webull either agrees with or confirms the truthfulness or accuracy of the information. It should not be considered as investment advice from Webull or anyone else, nor should it be used as the basis of any investment decision.
What's Trending